Stephen Marcus

697 total citations
33 papers, 526 citations indexed

About

Stephen Marcus is a scholar working on Hematology, Surgery and Oncology. According to data from OpenAlex, Stephen Marcus has authored 33 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Surgery and 7 papers in Oncology. Recurrent topics in Stephen Marcus's work include Multiple Myeloma Research and Treatments (6 papers), Acute Myeloid Leukemia Research (4 papers) and Platelet Disorders and Treatments (4 papers). Stephen Marcus is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Acute Myeloid Leukemia Research (4 papers) and Platelet Disorders and Treatments (4 papers). Stephen Marcus collaborates with scholars based in United States, Spain and Japan. Stephen Marcus's co-authors include Thomas J. Green, Walter P. Dembitsky, Pat O. Daily, Robert Adamson, Prakash Chinnaiyan, Ricardo J. Moreno-Cabral, Richard K. Freeman, Rekha Chaudhary, Adam L. Cohen and Samuel Goldlust and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Stephen Marcus

32 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Marcus United States 14 145 94 90 77 73 33 526
Mikael Åberg Sweden 14 174 1.2× 70 0.7× 50 0.6× 99 1.3× 113 1.5× 40 577
Catherine Ross Canada 16 290 2.0× 58 0.6× 109 1.2× 164 2.1× 171 2.3× 37 936
Jeffrey R. Dahlen United States 13 301 2.1× 46 0.5× 52 0.6× 107 1.4× 124 1.7× 20 663
Jolanta E. Kunicka United States 12 189 1.3× 73 0.8× 138 1.5× 219 2.8× 121 1.7× 25 713
Laurent Antunes France 14 304 2.1× 112 1.2× 134 1.5× 71 0.9× 39 0.5× 26 800
Tzu‐Hung Hsiao Taiwan 12 191 1.3× 52 0.6× 72 0.8× 52 0.7× 54 0.7× 76 468
Roberto Caporale Italy 14 243 1.7× 31 0.3× 102 1.1× 123 1.6× 150 2.1× 23 633
Zhongming Yang China 10 193 1.3× 48 0.5× 54 0.6× 61 0.8× 98 1.3× 23 1.5k
Donal P. Hayes Netherlands 6 132 0.9× 77 0.8× 57 0.6× 44 0.6× 46 0.6× 8 566
Yan-Ming Chen Taiwan 16 96 0.7× 100 1.1× 67 0.7× 31 0.4× 24 0.3× 45 644

Countries citing papers authored by Stephen Marcus

Since Specialization
Citations

This map shows the geographic impact of Stephen Marcus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Marcus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Marcus more than expected).

Fields of papers citing papers by Stephen Marcus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Marcus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Marcus. The network helps show where Stephen Marcus may publish in the future.

Co-authorship network of co-authors of Stephen Marcus

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Marcus. A scholar is included among the top collaborators of Stephen Marcus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Marcus. Stephen Marcus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valiente, Manuel, María Ángeles Vaz Salgado, Estela Pineda, et al.. (2024). Azeliragon, a RAGE inhibitor, in combination with temozolomide and radiotherapy in patients with newly diagnosed glioblastoma: Phase Ib/II CAN-201 NDG trial design.. Journal of Clinical Oncology. 42(16_suppl). TPS2096–TPS2096. 3 indexed citations
2.
Segura‐Collar, Berta, R. Contreras, Manuel Valiente, et al.. (2024). S100A proteins show a spatial distribution of inflammation associated with the glioblastoma microenvironment architecture. Theranostics. 15(2). 726–744. 1 indexed citations
3.
4.
Rettig, Michael P., Amanda F. Cashen, John F. DiPersio, et al.. (2021). Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDS. Leukemia Research. 110. 106713–106713. 14 indexed citations
5.
Huang, Jiayi, Rekha Chaudhary, Adam L. Cohen, et al.. (2019). A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma. Journal of Neuro-Oncology. 142(3). 537–544. 82 indexed citations
6.
Kovacsovics, Tibor, Alice S. Mims, Mohamed E. Salama, et al.. (2015). O-desulfated heparin and chemotherapy for the treatment of AML.. Journal of Clinical Oncology. 33(15_suppl). 7053–7053. 3 indexed citations
7.
8.
Sigal, Darren, Stephen Marcus, Peter J. Rosen, et al.. (2013). Association of 2-O, 3-O desulfated heparin (ODSH) plus combination gemcitabine (G)/nab-paclitaxel (A) with preliminary benefit in untreated metastatic pancreatic cancer.. Journal of Clinical Oncology. 31(4_suppl). 284–284. 5 indexed citations
9.
Kowalska, M. Anna, Guohua Zhao, Li Zhai, et al.. (2013). Modulation of Protein C Activation by Histones, Platelet Factor 4, and Heparinoids. Arteriosclerosis Thrombosis and Vascular Biology. 34(1). 120–126. 21 indexed citations
10.
Marcus, Stephen, et al.. (2012). Disruption of PF4/H multimolecular complex formation with a minimally anticoagulant heparin (ODSH). Thrombosis and Haemostasis. 107(4). 717–725. 23 indexed citations
11.
Loubser, Paul G., Joseph Schmoker, Robert W. Battle, et al.. (2003). Blood conservation strategies in Jehovah’s Witness patients undergoing complex aortic surgery: a report of three cases. Journal of Cardiothoracic and Vascular Anesthesia. 17(4). 528–535. 13 indexed citations
12.
Long, Zhifeng, Stephen N. Mueller, Patricia C. Ryan, et al.. (1998). Biosafety Monitoring of Patients Receiving Intracerebral Injections of Murine Retroviral Vector Producer Cells. Human Gene Therapy. 9(8). 1165–1172. 44 indexed citations
13.
Daily, Pat O., Richard K. Freeman, Walter P. Dembitsky, et al.. (1996). Cost reduction by combined carotid endarterectomy and coronary artery bypass grafting. Journal of Thoracic and Cardiovascular Surgery. 111(6). 1185–1193. 61 indexed citations
14.
15.
Daily, Pat O., et al.. (1995). New technique for lesser saphenous vein harvesting. The Annals of Thoracic Surgery. 60(6). 1829–1830. 3 indexed citations
16.
Streckfus, Charles F., et al.. (1994). Parotid function and composition of parotid saliva among elderly edentulous African – American diabetics. Journal of Oral Pathology and Medicine. 23(6). 277–279. 29 indexed citations
17.
Fetell, Michael R., Edgar M. Housepian, Martin W. Oster, et al.. (1990). Intratumor administration of beta-interferon in recurrent malignant gliomas. A phase I clinical and laboratory study. Cancer. 65(1). 78–83. 28 indexed citations
18.
Vogel, Charles L., et al.. (1988). Phase II trial of recombinant Beta (IFN-Betaser) interferon in the treatment of metastatic breast cancer. Investigational New Drugs. 6(3). 211–215. 4 indexed citations
19.
Marcus, Stephen. (1984). Breakdown of P.G.E. 1 synthesis is responsible for the acquired immunodeficiency syndrome. Medical Hypotheses. 15(1). 39–46. 2 indexed citations
20.
Edwards, Brian, et al.. (1982). Coherent Laser Radar Remote Sensing. Defense Technical Information Center (DTIC). 83. 32053. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mikael Åberg Breakdown of academic impact, for papers by Catherine Ross Breakdown of academic impact, for papers by Jeffrey R. Dahlen Breakdown of academic impact, for papers by Jolanta E. Kunicka Breakdown of academic impact, for papers by Laurent Antunes Breakdown of academic impact, for papers by Tzu‐Hung Hsiao Breakdown of academic impact, for papers by Roberto Caporale Breakdown of academic impact, for papers by Zhongming Yang Breakdown of academic impact, for papers by Donal P. Hayes Breakdown of academic impact, for papers by Yan-Ming Chen
Rankless by CCL
2026